Are you or someone you know living with a Variant of Uncertain Significance (VUS) in an inherited cancer gene?
We’re inviting you to enroll into ICARE to be considered for a valuable research effort focused on improving resources for those with a VUS result. When you participate in ICARE, you’ll:
Be considered for this and other targeted research studies Receive inherited cancer treatment and management updates through newsletters and email Contribute data to advance research and help others affected by cancer
To learn more about participating and to enroll online, please visit https://redcap.link/ICAREconsent